£79.98

Humana Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Price data last checked 147 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£80 today · all-time low £79 (May 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 584 days • 584 data points (No recent data available)

Historical
Generating forecast...
£95.64 £77.62 £81.55 £85.48 £89.42 £93.35 £97.28 09 June 2024 01 November 2024 27 March 2025 20 August 2025 13 January 2026

Price Distribution

Price distribution over 584 days • 3 price levels

Days at Price
Current Price
404 days · current 147 days · current 33 days 0 101 202 303 404 £79 £80 £96 Days at Price

Price Analysis

Most common price: £79 (404 days, 69.2%)

Price range: £79 - £96

Price levels: 3 different prices over 584 days

Description

This succinct resource provides an ideal balance of the biology and practical therapeutic strategies for classic and non-classic BCR-ABL-negative myeloproliferative neoplasms. Utilizing current World Health Organization nomenclature, classification, and diagnostic criteria, international experts have assembled to convey the most up-to-date knowledge in this rapidly evolving field. The opening chapters cover the diagnosis and classification, genetics, cytogenetic findings, and prognostic factors of MPNs. Further chapters explore therapies specific to the different disease entities, including polycythemia vera, essential thrombocytopenia, myelofibrosis, and eosinophilic disorders, and mastocytosis. Unique areas of discussion include JAK2 inhibitor therapy, hematopoietic stem cell transplantation, and blastic transformation. A valuable reference for practicing hematologists, this forefront book enriches our understanding of recent discoveries and their impact on conventional and investigational treatments.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Publication Date
01 December 2012
Listed Since
16 November 2012

Barcode

No barcode data available

Similar Products You Might Like

Myeloproliferative Neoplasms: Critical Concepts and Management (Hematologic Malignancies)
98% match

Myeloproliferative Neoplasms: Critical Concepts and Management (Hematologic Malignancies)

Springer

£84.25 23 Feb 2026
Managing Myeloproliferative Neoplasms: A Case-Based Approach
98% match

Managing Myeloproliferative Neoplasms: A Case-Based Approach

Cambridge University Press

£52.33 08 Mar 2026
Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)
98% match

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Elsevier

£71.63 26 Feb 2026
Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)
98% match

Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)

Oxford University Press

£68.99 01 Mar 2026
Contemporary Management of Myeloproliferative Neoplasms
97% match

Contemporary Management of Myeloproliferative Neoplasms

Jaypee Brothers Medical Publishers

£71.53 28 Feb 2026
Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)
97% match

Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

Nova Science Publishers Inc

£47.46 22 Feb 2026
Myeloproliferative Disorders (Hematologic Malignancies)
97% match

Myeloproliferative Disorders (Hematologic Malignancies)

Springer

£94.99 21 Feb 2026
Myeloproliferative Disorders (Hematologic Malignancies)
97% match

Myeloproliferative Disorders (Hematologic Malignancies)

Springer

£84.58 01 Feb 2026
Molecular Hematology
97% match

Molecular Hematology

Wiley-Blackwell

£128.43 25 Feb 2026
Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America (Volume 26-5) (The Clinics: Internal Medicine, Volume 26-5)
97% match

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America (Volume 26-5) (The Clinics: Internal Medicine, Volume 26-5)

Saunders

£53.59 11 Apr 2026
Postgraduate Haematology
97% match

Postgraduate Haematology

Wiley-Blackwell

£56.55 11 Jan 2026
Desk Reference for Hematology
97% match

Desk Reference for Hematology

CRC Press

£254.48 06 Feb 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

£116.62 13 Jan 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£122.70 07 Mar 2026
Humana Hematological Malignancies - Methods in Molecular Biology
97% match

Humana Hematological Malignancies - Methods in Molecular Biology

Humana

£104.04 19 Apr 2026
Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)
97% match

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£68.52 26 Feb 2026
Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)
97% match

Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)

CRC Press

£142.02 02 Mar 2026
Hoffbrand's Postgraduate Haematology
97% match

Hoffbrand's Postgraduate Haematology

£149.50 12 Jan 2026
Hoffbrand's Essential Haematology, 8th Edition (Essentials)
97% match

Hoffbrand's Essential Haematology, 8th Edition (Essentials)

Wiley-Blackwell

£44.83 15 Dec 2025
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
97% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)
96% match

MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)

£104.18 13 Jan 2026
Hematopathology: Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches
96% match

Hematopathology: Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches

Academic Press

£26.27 10 Feb 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
96% match

Acute Myeloid Leukemia (Hematologic Malignancies)

£92.25 08 Jan 2026
Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)
96% match

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Humana

£84.99 17 Mar 2026